Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), a clinical-stage pharmaceutical company developing IKT-001 for Pulmonary Arterial Hypertension (“PAH”), announced today that ...

Patients who have heart failure with preserved ejection fraction (HFpEF) and high blood pressure in the lungs (pulmonary ...

The algorithm integrates with EHR systems and ECG platforms, operating within the health system without external data ...

Patients who have heart failure with preserved ejection fraction (HFpEF) and high blood pressure in the lungs (pulmonary hypertension) experienced significant improvements in blood pressure and ...

Merck (NYSE:MRK) is approaching phase 2 data for Winrevair in pulmonary hypertension. Results will focus on the 6 minute walk ...

PH is a progressive, life-threatening pulmonary vascular disease estimated to affect up to 1% of the global population. 1 It is often difficult to diagnose 2 due to non-specific early symptoms, such ...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that British Columbia, Non-Insured Health Benefits (NIHB), Nova Scotia, Quebec and Veterans Affairs Canada (VAC ...

India, March 29 -- Progressive pulmonary fibrosis (PPF), a serious form of interstitial lung disease, remains one of the most difficult lung conditions to treat.

In late March 2026, Liquidia’s Chief Commercial Officer Scott Moomaw exercised and immediately sold 80,000 shares under a pre-arranged Rule 10b5-1 trading plan, while retaining 188,954 shares. Around ...

Temple’s leadership in lung transplantation is inseparable from its role as an academic institution conducting cutting-edge ...

Laura Storr, who moved to Saudia Arabia for work in 2020, needs a lung transplant. Her family is raising money to medically ...

Detailed price information for Tenax Therapeutics (TENX-Q) from The Globe and Mail including charting and trades.